Palisade Bio, Inc.
PALI· Nasdaq
PALIPalisade Bio, Inc.
Released Mar 22, 2019, after the close
10-K filed Mar 22, 2019, 81 days after period end · 0001171843-19-001917
derived · Computed from the longer spans the company filed.
| Metric | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures | Q4 2015 |
|---|---|---|---|---|
| Revenue | $2.50K | $252.50K | $8.75K | $2.50K |
| Net Income | -$320.32K | -$3.32M |
Palisade Bio, Inc. · CIK 1357459 · Engraved from SEC EDGAR
| -$5.40M |
| -$4.77M |
| EPS Diluted | — | — | — | -$0.05 |
|---|
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
